Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million Biologics Test...

November 29, 2023 | Wednesday | News
Samsung Biologics engages suppliers to advance global decarbonization targets

The company invited supplier companies and external ESG specialists to discuss ESG-related requirements and recommendations as well as share successful cas...

November 28, 2023 | Tuesday | News
Hovione Acquires ExtremoChem for Biopharmaceutical Stabilization and Delivery

Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecule...

November 17, 2023 | Friday | News
Emergent CEO, Haywood Miller, Highlights Financial Growth and Opioid Crisis Response Efforts as Company Pursues Resilient Future.

Emergent BioSolutions Inc. (NYSE: EBS) today reported selected financial results for the third quarter ended September 30, 2023. The selected financia...

November 09, 2023 | Thursday | Company results
Evonik strengthens its portfolio of nanoparticle technologies and services for parenteral drug delivery

Three block copolymers added to RESOMER® portfolio of bioabsorbable polymers  New nanoparticle process technology increases options for n...

October 25, 2023 | Wednesday | News
Vetter Plans Expansion to Meet Growing Supply Chain Demands

Committed to sustainable growth and long-term planning Dedicated to making investments to support increased customer demand Maintain efficiency a...

October 18, 2023 | Wednesday | News
Samsung Bioepis Presents Phase 1 and 3 Clinical Results for SB16 Biosimilar to Prolia at ASBMR 2023

Phase 1 study for SB16, proposed biosimilar to Prolia, demonstrates pharmacokinetic (PK) bioequivalence between SB16, EU-sourced denosumab, and US-source...

October 16, 2023 | Monday | News
AGC Biologics Completes pDNA and mRNA Line Expansion in Heidelberg

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the completion of the facilit...

October 13, 2023 | Friday | News
Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing

Charles River Laboratories International, Inc.  announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™. The pl...

September 27, 2023 | Wednesday | News
Merck Becomes First CTDMO to Offer Comprehensive mRNA Development and Manufacturing Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...

September 27, 2023 | Wednesday | News
Lonza's Sudden CEO Departure: What's Behind the Curtain?

"Swiss CDMO Lonza Announces CEO Departure by Mutual Agreement; Chairman Baehny Takes the Helm Again Temporarily" Lonza, the Swiss Contract Development and...

September 18, 2023 | Monday | News
Syneos Health and Oracle Partner to Advance Patient Recruitment and Health Equity

Syneos Health is evolving its patient recruitment capabilities to further address unmet sponsor, site and patient needs. Through its collaboration with the...

September 13, 2023 | Wednesday | News
HumanFirst Launches Enterprise Platform for Clinical Research Advancements

HumanFirst, a cloud-based software company accelerating patient-centered drug development through AI-powered insights, today announced the launch of the in...

September 11, 2023 | Monday | News
CDMO player Enzene Biosciences opens new R&D centre in India

  Enzene Biosciences, a subsidiary of Mumbai-India, based Alkem Laboratories, has announced the inauguration of its cutting-edge research and...

September 07, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in